88 related articles for article (PubMed ID: 1581939)
1. [Colestipol in the treatment of heterozygous familial hypercholesterolemia].
Ceska R; Sobra J; Toschnerová H; Traurig J
Cas Lek Cesk; 1992 Mar; 131(4):118-20. PubMed ID: 1581939
[TBL] [Abstract][Full Text] [Related]
2. [Combined therapy of hyperlipoproteinemia. Colestipol and gemfibrozil in the treatment of heterozygous familial hypercholesterolemia].
Ceska R; Sobra J; Toschnerová H; Traurig J
Cas Lek Cesk; 1992 Mar; 131(6):183-5. PubMed ID: 1586935
[TBL] [Abstract][Full Text] [Related]
3. [Small doses of the resin Colestid in the treatment of hyperlipoproteinemia].
Válek J; Jirkovská A; Grafnetter D
Cas Lek Cesk; 1991 Feb; 130(6):172-6. PubMed ID: 2004412
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
5. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
[TBL] [Abstract][Full Text] [Related]
6. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
[TBL] [Abstract][Full Text] [Related]
8. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
9. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
[TBL] [Abstract][Full Text] [Related]
10. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
[No Abstract] [Full Text] [Related]
11. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
12. Treatment of familial hypercholesterolemia with drugs in children.
Stein EA
Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428
[TBL] [Abstract][Full Text] [Related]
13. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
[No Abstract] [Full Text] [Related]
14. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
Geiss HC; Schwandt P; Parhofer KG
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
Weisweiler P; Merk W; Jacob B; Schwandt P
Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.
Lind S; Rudling M; Ericsson S; Olivecrona H; Eriksson M; Borgström B; Eggertsen G; Berglund L; Angelin B
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):349-56. PubMed ID: 14656733
[TBL] [Abstract][Full Text] [Related]
18. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
[TBL] [Abstract][Full Text] [Related]
19. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
